Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Information provided by (Responsible Party):
Marie Schneider, Policlinique Médicale Universitaire
ClinicalTrials.gov Identifier:
NCT01621412
First received: May 31, 2012
Last updated: June 13, 2012
Last verified: June 2012

May 31, 2012
June 13, 2012
April 2012
November 2012   (final data collection date for primary outcome measure)
Patient Adherence [ Time Frame: 30 days before survey ] [ Designated as safety issue: No ]
Electronic monitoring of adherence during 30 days before survey
Same as current
Complete list of historical versions of study NCT01621412 on ClinicalTrials.gov Archive Site
Patient Adherence [ Time Frame: 90 days before survey ] [ Designated as safety issue: No ]
Electronic monitoring of adherence during 90 days before survey
Same as current
Not Provided
Not Provided
 
HIV Disclosure and Medication Adherence, a Pilot Study
HIV Disclosure and Medication Adherence, a Pilot Study

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Patients enrolled in the adherence-enhancing program at ther pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne

HIV Infection
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
120
March 2013
November 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV Infection
  • Enrolled in the adherence-enhancing program

Exclusion Criteria:

  • Inclusion visit
  • Not french or english speaker
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT01621412
RSAD-VIH-2011
No
Marie Schneider, Policlinique Médicale Universitaire
Policlinique Médicale Universitaire
  • Centre Hospitalier Universitaire Vaudois
  • Swiss HIV Cohort Study
Principal Investigator: Marie-Paule Schneider, PhD Policlinique Médicale Universitaire
Principal Investigator: Aurélie Gertsch, PhD-Student Policlinique Médicale Universitaire
Study Chair: Olivier Bugnon, Professor Policlinique Médicale Universitaire
Study Chair: Matthias Cavassini, MD Centre Hospitalier Universitaire Vaudois
Policlinique Médicale Universitaire
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP